Table 2.
Clinical and hospitalization data in patients developing post-COVID cognitive symptoms at T1 or T2 follow-up periods
| Memory loss | Memory loss | Brain fog | Brain fog | Concentration loss | Concentration loss | |
|---|---|---|---|---|---|---|
| (T1, N = 99) | (T2, n = 101) | (T1, n = 42) | (T2, n = 43) | (T1, n = 36) | (T2, n = 39) | |
| Age (years), mean ± SD | 66.5 ± 14.0 | 62.5 ± 14.0 | 55.0 ± 16.0 | 62.5 ± 14.5 | 67.0 ± 16.0 | 63.0 ± 12.5 |
| Weight (kg), mean ± SD | 74.2 ± 13.7 | 73.6 ± 14.5 | 74.0 ± 11.5 | 73.6 ± 13.7 | 75.1 ± 16.9 | 80.0 ± 23.2 |
| Height (cm), mean ± SD | 165.0 ± 10.5 | 164.0 ± 9.5 | 162.0 ± 7.0 | 163.5 ± 9.7 | 166.0 ± 12.0 | 167.0 ± 12.0 |
| Female, n (%) | 52 (52.5%) | 55 (54.5%) | 26 (61.9%) | 23 (53.5%) | 21 (58.3%) | 22 (56.5%) |
| Medical co-morbidities | ||||||
| Hypertension, n (%) | 33 (33.3%) | 32 (31.7%) | 6 (14.3%) | 14 (32.5%) | 15 (41.7%) | 11 (28.2%) |
| Diabetes, n (%) | 21 (21.1%) | 11 (10.9%) | 5 (11.9%) | 7 (16.3%) | 10 (27.8%) | 5 (12.8%) |
| Cardiovascular disease | 21 (21.1%) | 11 (10.9%) | 2 (4.75%) | 4 (9.3%) | 8 (22.2%) | 6 (15.4%) |
| Asthma, n (%) | 11 (11.1%) | 6 (5.95%) | 5 (11.9%) | 3 (7%) | 4 (11.1%) | 4 (10.26%) |
| Obesity, n (%) | 3 (3.0%) | 6 (5.95%) | 6 (14.3%) | 0 (0%) | 3 (8.3%) | 6 (15.4%) |
| COPD, n (%) | 5 (5.05%) | 5 (4.95%) | 1 (2.4%) | 1 (2.3%) | 3 (8.3%) | 3 (7.7%) |
| Rheumatological disease | 2 (2%) | 2 (2%) | 1 (2.4%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Other, n (%) | 26 (26.25%) | 17 (16.85%) | 5 (11.9%) | 6 (13.95%) | 12 (33.3%) | 7 (17.95%) |
| Number of onset symptoms at hospital admission | 2.3 ± 0.75 | 2.35 ± 0.8 | 2.2 ± 0.8 | 2.5 ± 0.6 | 2.1 ± 1.0 | 2.4 ± 0.9 |
| Symptoms at hospitalization | ||||||
| Fever, n (%) | 71 (71.7%) | 75 (74.25%) | 30 (71.4%) | 32 (74.5%) | 24 (66.7%) | 25 (64.1%) |
| Dyspnoea, n (%) | 36 (36.35%) | 29 (28.7%) | 10 (23.8%) | 18 (41.9%) | 15 (41.7%) | 14 (35.9%) |
| Myalgia, n (%) | 30 (30.3%) | 30 (29.7%) | 12 (28.6%) | 17 (39.5%) | 14 (38.9%) | 13 (33.3%) |
| Cough, n (%) | 23 (23.25%) | 28 (27.7%) | 12 (28.6%) | 6 (14%) | 9 (25%) | 7 (17.95%) |
| Headache, n (%) | 21 (21.1%) | 23 (22.8%) | 4 (9.5%) | 11 (25.6%) | 4 (11.1%) | 8 (20.5%) |
| Vomiting, n (%) | 3 (3%) | 3 (3%) | 2 (4.8%) | 1 (2.3%) | 0 (0%) | 2 (5.1%) |
| Anosmia, n (%) | 11 (11.1%) | 10 (9.9%) | 4 (9.5%) | 6 (13.95%) | 3 (8.3%) | 9 (23.1%) |
| Ageusia, n (%) | 9 (9.1%) | 11 (10.9%) | 1 (2.4%) | 3 (7%) | 1 (2.8%) | 3 (7.7%) |
| Dizziness, n (%) | 7 (7.1%) | 5 (4.95%) | 3 (7.15%) | 2 (4.65%) | 1 (2.8%) | 4 (10.25%) |
| Days at hospital, mean ± SD | 9.8 ± 9.65 | 12.5 ± 11.2 | 8.0 ± 7.5 | 10.3 ± 12.95 | 10.5 ± 8.6 | 12.4 ± 10.9 |
| ICU admission, n (%) | 4 (4.05%) | 5 (4.95%) | 1 (2.4%) | 3 (7%) | 0 (0%) | 3 (7.7%) |